Fenspiride

CHEMBL576127 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
260.3 g/mol
LogP
2.1
Phase
4

A bronchodilator and anti-inflammatory medication used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease. It works by relaxing the airways and reducing inflammation in the bronchial passages. This medicine helps improve breathing and reduce the frequency of respiratory symptoms.

Masse moléculaire

260,3300 g/mol

LogP

2,10

TPSA

41,60 Ų

Règle des 5 de Lipinski

Conforme

Mécanisme d'action

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C1NCC2(CCN(CCc3ccccc3)CC2)O1

InChI

InChI=1S/C15H20N2O2/c18-14-16-12-15(19-14)7-10-17(11-8-15)9-6-13-4-2-1-3-5-13/h1-5H,6-12H2,(H,16,18)

Molecular Formula

C15H20N2O2

HBD / HBA

1 / 3

Liaisons Rotatives

3

Atomes Lourds

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A bronchodilator and anti-inflammatory medication used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease. It works by relaxing the airways and reducing inflammation in the bronchial passages. This medicine helps improve breathing and reduce the frequency of respiratory symptoms.

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

Yes, Fenspiride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL576127. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3344. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.